Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-17

FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approves a supplemental application for testosterone filed by Prasco Laboratories under NDA 022309. This action grants supplemental approval for the testost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)